Pierpaolo De Francesco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pierpaolo De Francesco has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ilaria Giovannacci
Oral Medicine and Oral Laser Surgery Unit, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43125 Parma, Italy
6 shared publications - Paolo Vescovi
Oral Medicine and Oral Laser Surgery Unit, Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43125 Parma, Italy
6 shared publications - Roberta Iaria
Department of Medicine and Surgery, Oral Medicine and Oral Surgery Laser Unit, University Center of Dentistry, University of Parma, Parma
2 shared publications - Antonio Barone
Department of Surgical, Medical, Molecular Pathology and of the Critical Area, University of Pisa, 56126 Pisa, Italy
1 shared publication - Carmen Mortellaro
UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy, unicamillus.org
1 shared publication Claudia Grondelli
Department of Radiation Oncology and Radiosurgery, University Hospital of Parma, Parma, Italy, parmahospital.org
1 shared publication
Latest Publications
- Open Access
- 5 July 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (7) , 408
Protective and Healing Effects of Zinc L-Carnosine on the Oral Mucosa: A Systematic Review and Meta-Analysis
Background/Objectives: Oral mucosal injury is a frequent complication in oncologic and surgical settings, significantly affecting patient quality of life. Zinc L-carnosine (ZnC) is a cytoprotective compound with anti-inflammatory, antioxidant, and epithelial reparative properties. This systematic review evaluated its protective and healing effects on oral mucosa. Methods: A systematic search followed PRISMA guidelines was conducted across PubMed, Scopus, Web of Science, and Cochrane Library (2015–2026). Randomized and non-randomized controlled studies assessing ZnC in patients with or at risk of oral mucosal injury were included. Risk of bias was evaluated using RoB 2 and ROBINS-I tools. Meta-analyses were conducted under both common- and random-effects models. The certainty of evidence was evaluated according to the GRADE guidelines. Results: Eight studies (n = 544) were included. Six non-randomized studies showed moderate or serious risk of bias, while randomized trials presented some concerns. ZnC was administered in different formulations, including mouthwashes, lozenges, and mucoadhesive suspensions based on sodium alginate, polyacrylic acid, and carboxyvinyl polymer, and across different clinical settings. Meta-analysis showed a reduced incidence of severe oral mucositis (grade ≥ 3) under the Common Effect model (OR 0.48; 95% CI 0.32–0.72), although statistical significance was not maintained under random-effects models (OR 0.44; 95% CI 0.18–1.06). Similar results were observed for grade ≥ 2 mucositis. According to the GRADE assessment, the certainty of evidence was low for oral mucositis outcomes and very low for oral mucosal healing. Only one study suggested improved surgical wound healing. No serious adverse events were reported. Conclusions: ZnC may support oral mucosal protection and healing, particularly in preventing oral mucositis. However, substantial heterogeneity and limited high-quality randomized evidence restrict the strength of conclusions. Further well-designed randomized trials are needed.
- 5 July 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (7) , 408
Open AccessProtective and Healing Effects of Zinc L-Carnosine on the Oral Mucosa: A Systematic Review and Meta-Analysis
Background/Objectives: Oral mucosal injury is a frequent complication in oncologic and surgical settings, significantly affecting patient quality of life. Zinc L-carnosine (ZnC) is a cytoprotective compound with anti-inflammatory, antioxidant, and epithelial reparative properties. This systematic review evaluated its protective and healing effects on oral mucosa. Methods: A systematic search followed PRISMA guidelines was conducted across PubMed, Scopus, Web of Science, and Cochrane Library (2015–2026). Randomized and non-randomized controlled studies assessing ZnC in patients with or at risk of oral mucosal injury were included. Risk of bias was evaluated using RoB 2 and ROBINS-I tools. Meta-analyses were conducted under both common- and random-effects models. The certainty of evidence was evaluated according to the GRADE guidelines. Results: Eight studies (n = 544) were included. Six non-randomized studies showed moderate or serious risk of bias, while randomized trials presented some concerns. ZnC was administered in different formulations, including mouthwashes, lozenges, and mucoadhesive suspensions based on sodium alginate, polyacrylic acid, and carboxyvinyl polymer, and across different clinical settings. Meta-analysis showed a reduced incidence of severe oral mucositis (grade ≥ 3) under the Common Effect model (OR 0.48; 95% CI 0.32–0.72), although statistical significance was not maintained under random-effects models (OR 0.44; 95% CI 0.18–1.06). Similar results were observed for grade ≥ 2 mucositis. According to the GRADE assessment, the certainty of evidence was low for oral mucositis outcomes and very low for oral mucosal healing. Only one study suggested improved surgical wound healing. No serious adverse events were reported. Conclusions: ZnC may support oral mucosal protection and healing, particularly in preventing oral mucositis. However, substantial heterogeneity and limited high-quality randomized evidence restrict the strength of conclusions. Further well-designed randomized trials are needed.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1) , 7025093
A Case Series on the Combined Use of Zinc L‐Carnosine and Nd:YAG Photobiomodulation for Radiation‐Induced Oral Mucositis: Pain Reduction and Lesion Improvement
Radiation‐induced oral mucositis (RIOM) is a severe complication in patients with head and neck cancer (HNC) undergoing radiotherapy (RT). Despite several proposed strategies for prevention and treatment, the results remain inconsistent and unpredictable. A combined approach with zinc L‐carnosine (ZnC) mouthwash and Nd:YAG laser photobiomodulation (PBM) was evaluated in three patients affected by RIOM, treated at the Unit of Oral Medicine, Pathology and Laser‐assisted Surgery of the University of Parma, Italy. One patient had oropharyngeal cancer, one had tongue cancer, and one had soft palate cancer. Two patients presented with World Health Organization (WHO) grade III mucositis, and one with WHO grade II mucositis. The percentage reduction in oral lesions was calculated using Fiji software. All patients reported clinical improvement and a reduction in algic symptoms. A significant decrease in pain was observed after only 2 days, while complete mucosal healing was achieved within 3 weeks. These preliminary results suggest that the combined use of ZnC and Nd:YAG laser PBM may be a promising therapeutic option for patients affected by RIOM, warranting further investigation in larger clinical studies.
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1) , 7025093
Open AccessA Case Series on the Combined Use of Zinc L‐Carnosine and Nd:YAG Photobiomodulation for Radiation‐Induced Oral Mucositis: Pain Reduction and Lesion Improvement
Radiation‐induced oral mucositis (RIOM) is a severe complication in patients with head and neck cancer (HNC) undergoing radiotherapy (RT). Despite several proposed strategies for prevention and treatment, the results remain inconsistent and unpredictable. A combined approach with zinc L‐carnosine (ZnC) mouthwash and Nd:YAG laser photobiomodulation (PBM) was evaluated in three patients affected by RIOM, treated at the Unit of Oral Medicine, Pathology and Laser‐assisted Surgery of the University of Parma, Italy. One patient had oropharyngeal cancer, one had tongue cancer, and one had soft palate cancer. Two patients presented with World Health Organization (WHO) grade III mucositis, and one with WHO grade II mucositis. The percentage reduction in oral lesions was calculated using Fiji software. All patients reported clinical improvement and a reduction in algic symptoms. A significant decrease in pain was observed after only 2 days, while complete mucosal healing was achieved within 3 weeks. These preliminary results suggest that the combined use of ZnC and Nd:YAG laser PBM may be a promising therapeutic option for patients affected by RIOM, warranting further investigation in larger clinical studies.
- Open Access
- 24 November 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 37 (6) , 1455-1460
Are Buccal Fat Pad–Derived Stem Cells Effective in Adults for Maxillary Bone Regeneration? A Systematic Review
Critical-size bone defects in the maxillofacial region remain a major challenge. Although autografts are widely used, they are limited by donor-site morbidity and graft availability. Tissue engineering with mesenchymal stem cells, particularly buccal fat pad-derived stem cells (BFPSCs), offers a promising alternative due to their accessibility and osteogenic potential. This systematic review assesses clinical evidence on the use of BFPSCs for regenerating oro-maxillofacial bone defects in adults. A systematic search was conducted in PubMed/MEDLINE, EMBASE, and Cochrane databases for studies from January 2015 to September 2025. Inclusion criteria were in vivo human studies using BFPSCs for maxillofacial bone regeneration. Excluded were in vitro, animal studies, cell-free BFP applications, and non-original articles. Two reviewers independently screened studies; discrepancies were resolved by a senior reviewer. The level of evidence was assessed using Oxford CEBM criteria. Out of 375 identified articles, 6 clinical studies (including one randomized trial) involving 49 patients met inclusion criteria. BFPSCs were applied alone or with autologous bone. All studies reported favorable clinical and radiologic outcomes; some included histologic data confirming new bone formation. BFPSCs demonstrate promising potential for maxillofacial bone regeneration. However, high-quality studies are needed to confirm effectiveness and define standardized protocols.
- 24 November 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 37 (6) , 1455-1460
Open AccessAre Buccal Fat Pad–Derived Stem Cells Effective in Adults for Maxillary Bone Regeneration? A Systematic Review
Critical-size bone defects in the maxillofacial region remain a major challenge. Although autografts are widely used, they are limited by donor-site morbidity and graft availability. Tissue engineering with mesenchymal stem cells, particularly buccal fat pad-derived stem cells (BFPSCs), offers a promising alternative due to their accessibility and osteogenic potential. This systematic review assesses clinical evidence on the use of BFPSCs for regenerating oro-maxillofacial bone defects in adults. A systematic search was conducted in PubMed/MEDLINE, EMBASE, and Cochrane databases for studies from January 2015 to September 2025. Inclusion criteria were in vivo human studies using BFPSCs for maxillofacial bone regeneration. Excluded were in vitro, animal studies, cell-free BFP applications, and non-original articles. Two reviewers independently screened studies; discrepancies were resolved by a senior reviewer. The level of evidence was assessed using Oxford CEBM criteria. Out of 375 identified articles, 6 clinical studies (including one randomized trial) involving 49 patients met inclusion criteria. BFPSCs were applied alone or with autologous bone. All studies reported favorable clinical and radiologic outcomes; some included histologic data confirming new bone formation. BFPSCs demonstrate promising potential for maxillofacial bone regeneration. However, high-quality studies are needed to confirm effectiveness and define standardized protocols.
- Open Access
Laser Photobiomodulation: What Are the Ideal Parameters for Each Type of Laser Used in Dental Practice to Promote Fibroblast Proliferation and Differentiation? A Systematic Review
Laser photobiomodulation (LPMB) is a non-invasive therapy that relies on the use of low-power lasers. The literature supports the positive effect of LPBM on tissue regeneration, since it reduces the timing of the inflammatory phase, promoting the proliferative phase of the process. From a purely clinical point of view, the breadth of lasers currently available for dental use makes it difficult to identify unambiguous parameters that can guarantee the best regenerative effect. Therefore, the aim of the present systematic review is to identify the best irradiation parameters for each type of dental laser that can provide the best effects on fibroblast proliferation and differentiation. The literature was searched through the following electronic databases: Medline, Scopus, Web of Science, Springer, and Cochrane, while respecting the PRISMA 2020 guidelines. In vitro studies conducted on human fibroblast cells, drafted in English between 2004 and 2025, were included. A total of 17 papers assessing the effects of diode lasers at different wavelengths (445 nm, 635 nm, 650 nm, 660 nm, 670 nm, 685 nm, 810 nm, 830 nm, 915 nm, 940 nm), CO2 lasers (10.6 µm), and Er:YAG lasers (2940 nm) were included. What can be concluded from the present review is that, for the same wavelength, the wide variability in the results obtained from each study makes it complicated to identify unambiguous parameters for each laser device that can guarantee the best effect on fibroblast proliferation and differentiation.
Open AccessLaser Photobiomodulation: What Are the Ideal Parameters for Each Type of Laser Used in Dental Practice to Promote Fibroblast Proliferation and Differentiation? A Systematic Review
Laser photobiomodulation (LPMB) is a non-invasive therapy that relies on the use of low-power lasers. The literature supports the positive effect of LPBM on tissue regeneration, since it reduces the timing of the inflammatory phase, promoting the proliferative phase of the process. From a purely clinical point of view, the breadth of lasers currently available for dental use makes it difficult to identify unambiguous parameters that can guarantee the best regenerative effect. Therefore, the aim of the present systematic review is to identify the best irradiation parameters for each type of dental laser that can provide the best effects on fibroblast proliferation and differentiation. The literature was searched through the following electronic databases: Medline, Scopus, Web of Science, Springer, and Cochrane, while respecting the PRISMA 2020 guidelines. In vitro studies conducted on human fibroblast cells, drafted in English between 2004 and 2025, were included. A total of 17 papers assessing the effects of diode lasers at different wavelengths (445 nm, 635 nm, 650 nm, 660 nm, 670 nm, 685 nm, 810 nm, 830 nm, 915 nm, 940 nm), CO2 lasers (10.6 µm), and Er:YAG lasers (2940 nm) were included. What can be concluded from the present review is that, for the same wavelength, the wide variability in the results obtained from each study makes it complicated to identify unambiguous parameters for each laser device that can guarantee the best effect on fibroblast proliferation and differentiation.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Dentistry
- Vol. 2025 (1) , 1229183
Mucocutaneous Leishmaniasis With Oral Involvement: A Case Report
The primary objective of the present study is the retrospective analysis of a clinical case of oral leishmaniasis treated at Parma Hospital and a review of the literature on mucosal leishmaniasis (ML) with oral cavity involvement. We report the case of a patient diagnosed in 2017 with mucocutaneous leishmaniasis who was referred to our clinic due to the emergence of oral manifestations. Through a detailed review of the clinical documentation, we aim to describe the clinical presentation, diagnosis, treatment choices made, and evolution of the disease. Literature describes various pharmacological approaches for leishmaniasis, with treatment selection dependent on clinical presentation. ML does not spontaneously resolve, and systemic therapy is necessary. Due to its rarity, oral leishmaniasis can be challenging to diagnose. This case report can help physicians recognize the clinical presentation of oral lesions, enabling prompt diagnosis and effective treatment.
- 1 January 2025
- Published by Wiley in Case Reports in Dentistry
- Vol. 2025 (1) , 1229183
Open AccessMucocutaneous Leishmaniasis With Oral Involvement: A Case Report
The primary objective of the present study is the retrospective analysis of a clinical case of oral leishmaniasis treated at Parma Hospital and a review of the literature on mucosal leishmaniasis (ML) with oral cavity involvement. We report the case of a patient diagnosed in 2017 with mucocutaneous leishmaniasis who was referred to our clinic due to the emergence of oral manifestations. Through a detailed review of the clinical documentation, we aim to describe the clinical presentation, diagnosis, treatment choices made, and evolution of the disease. Literature describes various pharmacological approaches for leishmaniasis, with treatment selection dependent on clinical presentation. ML does not spontaneously resolve, and systemic therapy is necessary. Due to its rarity, oral leishmaniasis can be challenging to diagnose. This case report can help physicians recognize the clinical presentation of oral lesions, enabling prompt diagnosis and effective treatment.
- Open Access
- 19 August 2024
- Published by MDPI AG in Dentistry Journal
- Vol. 12 (8) , 261
Piezoelectric Surgery, Er:YAG Laser Surgery and Nd:YAG Laser Photobiomodulation: A Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws (MRONJ)
Medication-related osteonecrosis of the jaw (MRONJ) is a drug complication that can occur in patients taking antiresorptive or antiangiogenic drugs. Although it is a well-documented disease, there is no widely accepted treatment. However, several therapeutic approaches have been proposed. The surgical approach in many advanced cases appears inevitable; however, the results are not yet defined and predictable. This study aimed to propose a combined surgical approach with a piezoelectric device and laser (Er:YAG for bone ablation and Nd:YAG laser for photobiomodulation) in a young patient with breast cancer and bone metastasis under denosumab treatment, affected by spontaneous stage 3 MRONJ with maxillary sinus involvement. The patient under study reported no post-operative discomfort, with painkiller intake limited to the day after surgery. Total mucosal healing was observed without recurrences for more than 4 years after surgery. According to the results of our preliminary study, a combined surgical approach using a piezoelectric device and laser therapy is effective in managing patients affected by MRONJ, leveraging the clinical and biological advantages of these different techniques.
- 19 August 2024
- Published by MDPI AG in Dentistry Journal
- Vol. 12 (8) , 261
Open AccessPiezoelectric Surgery, Er:YAG Laser Surgery and Nd:YAG Laser Photobiomodulation: A Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws (MRONJ)
Medication-related osteonecrosis of the jaw (MRONJ) is a drug complication that can occur in patients taking antiresorptive or antiangiogenic drugs. Although it is a well-documented disease, there is no widely accepted treatment. However, several therapeutic approaches have been proposed. The surgical approach in many advanced cases appears inevitable; however, the results are not yet defined and predictable. This study aimed to propose a combined surgical approach with a piezoelectric device and laser (Er:YAG for bone ablation and Nd:YAG laser for photobiomodulation) in a young patient with breast cancer and bone metastasis under denosumab treatment, affected by spontaneous stage 3 MRONJ with maxillary sinus involvement. The patient under study reported no post-operative discomfort, with painkiller intake limited to the day after surgery. Total mucosal healing was observed without recurrences for more than 4 years after surgery. According to the results of our preliminary study, a combined surgical approach using a piezoelectric device and laser therapy is effective in managing patients affected by MRONJ, leveraging the clinical and biological advantages of these different techniques.